These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 647679)

  • 21. Tumorigenicity of optical isomers of the diastereomeric bay-region 3,4-diol-1,2-epoxides of benzo(c)phenanthrene in murine tumor models.
    Levin W; Chang RL; Wood AW; Thakker DR; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1986 May; 46(5):2257-61. PubMed ID: 3697970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chrysene and methylchrysenes: presence in tobacco smoke and carcinogenicity.
    Hecht SS; Bondinell WE; Hoffmann D
    J Natl Cancer Inst; 1974 Oct; 53(4):1121-33. PubMed ID: 4427391
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative tumor-initiating activity of methylated benzo(a)pyrene derivatives in mouse skin.
    Iyer RP; Lyga JW; Secrist JA; Daub GH; Slaga TJ
    Cancer Res; 1980 Apr; 40(4):1073-6. PubMed ID: 7357537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumorigenic activity of benzo(e)pyrene derivatives on mouse skin and in newborn mice.
    Buening MK; Levin W; Wood AW; Chang RL; Lehr RE; Taylor CW; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1980 Feb; 40(2):203-6. PubMed ID: 7356502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylene-bridged bay region chrysene and phenanthrene derivatives and their keto-analogs: mutagenicity in Salmonella typhimurium and tumor-initiating activity on mouse skin.
    Rice JE; Makowski GS; Hosted TJ; Lavoie EJ
    Cancer Lett; 1985 Jun; 27(2):199-206. PubMed ID: 3891075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marked differences in the tumor-initiating activity of optically pure (+)- and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene on mouse skin.
    Levin W; Wood AW; Chang RL; Slaga TJ; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1977 Aug; 37(8 Pt 1):2721-5. PubMed ID: 872099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simple phorbol esters as inhibitors of tumor promotion by TPA in mouse skin.
    Schmidt R; Hecker E
    Carcinog Compr Surv; 1982; 7():57-63. PubMed ID: 7066929
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of the tumor-initiating activities of benzo(a)pyrene arene oxides and diol-epoxides.
    Slaga TJ; Bracken WM; Viaje A; Levin W; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1977 Nov; 37(11):4130-3. PubMed ID: 908047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of fluorine substitution on the tumor initiating activity and metabolism of 5-hydroxymethylchrysene, a tumorigenic metabolite of 5-methylchrysene.
    Amin S; Juchatz A; Furuya K; Hecht SS
    Carcinogenesis; 1981; 2(10):1027-32. PubMed ID: 7296756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative tumorigenicity of 6-nitrochrysene and its metabolites in newborn mice.
    el-Bayoumy K; Shiue GH; Hecht SS
    Carcinogenesis; 1989 Feb; 10(2):369-72. PubMed ID: 2912588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1,4-Dimethylphenanthrene.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():349-53. PubMed ID: 6586669
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of 6-nitro substitution on 5-methylchrysene tumorigenicity, mutagenicity and metabolism.
    el-Bayoumy K; Amin S; Hecht SS
    Carcinogenesis; 1986 Apr; 7(4):673-6. PubMed ID: 3509952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism and tumorigenicity of 7-, 8-, 9-, and 10-fluorobenzo(a)pyrenes.
    Buhler DR; Unlu F; Thakker DR; Slaga TJ; Newman MS; Levin W; Conney AH; Jerina DM
    Cancer Res; 1982 Nov; 42(11):4779-83. PubMed ID: 6290047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzo[c]phenanthrene.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():205-9. PubMed ID: 6586652
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of the mutagenicity of compounds of known carcinogenicity, belonging to the benz[a]anthracene, chrysene, and cyclopenta[a]phenanthrene series, using Ames's test.
    Coombs MM; Dixon C; Kissonerghis AM
    Cancer Res; 1976 Dec; 36(12):4525-9. PubMed ID: 793712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between carcinogenicity and chemical structure in cyclopenta(a)phenanthrenes.
    Coombs MM; Bhatt TS; Croft CJ
    Cancer Res; 1973 Apr; 33(4):832-7. PubMed ID: 4696480
    [No Abstract]   [Full Text] [Related]  

  • 37. Mutagenicity, tumor-initiating activity, and metabolism of methylphenanthrenes.
    LaVoie EJ; Tulley-Freiler L; Bedenko V; Hoffman D
    Cancer Res; 1981 Sep; 41(9 Pt 1):3441-7. PubMed ID: 7020927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 6-Nitrochrysene.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1984 Apr; 33():195-200. PubMed ID: 6590453
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemoprevention of cancer.
    Wattenberg LW
    Cancer Res; 1985 Jan; 45(1):1-8. PubMed ID: 3880665
    [No Abstract]   [Full Text] [Related]  

  • 40. High tumorigenicity of the 3,4-dihydrodiol of 7-methylbenz[c]acridine on mouse skin and in newborn mice.
    Chang RL; Levin W; Wood AW; Shirai N; Ryan AJ; Duke CC; Jerina DM; Holder GM; Conney AH
    Cancer Res; 1986 Sep; 46(9):4552-5. PubMed ID: 3731110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.